CD33 is a myeloid-specific sialic acid-binding receptor overexpressed on the cell surface of 90% of AML blasts, and it has a role in regulating leukocyte functions in inflammatory and immune responses [15]. This evidence concerns the gene CD33 and acute myeloid leukemia.